Sequential measurement of serum amyloid A concentrations in ill hospitalized neonatal foals
Journal of Veterinary Internal Medicine · 2026
DOI: 10.1093/jvimsj/aalag035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2026. Verfasst von Astrid J van den Brom-Spierenburg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Serum Amyloid A Protein, Horse Diseases, Systemic Inflammatory Response Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
In hospitalized foals, limited data are available on the utility of sequential measurement of SAA concentrations and the value of these data in a clinical setting. Hypothesis/Objectives To determine serum amyloid A (SAA) concentrations in ill neonatal foals at multiple timepoints during hospitalization, and to evaluate a potential association with systemic inflammatory response syndrome (SIRS) status, blood culture (BC) result, and survival. Animals Hospitalized ill foals (n = 90, ≤ 14 days).
Methods
In this retrospective study, foals were classified based on SIRS criteria: “SIRS” or “NonSIRS,” BC results, and survival. Serum amyloid A concentrations on admission (ADM), day 1 (D1) and day 2 (D2) were compared within and between groups, using nonparametric tests. Results are presented as median (IQR) (effect size; 95% CI).
Results
Serum amyloid A concentrations were higher in SIRS than in NonSIRS foals both on ADM (401 mg/L (99; 855) vs 67 mg/L (23; 685), [ES 129, 95% CI, 15-385]), and on D1 (836 mg/L (616; 1240) vs 212 mg/L (69; 890), [ES 501, 95% CI, 121-724]). On D2, but not on ADM, foals with a positive BC had higher SAA (1244 mg/L (757; 2004)) than BC negative foals (153 mg/L (57; 695), [ES 1002; 95% CI, 282-1418]). On D1, but not on ADM, SAA was higher in non-survivors (729 mg/L (469; 1347) than in survivors (323 mg/L (75; 889), [ES 373; 95% CI, 28-651]). Conclusions and clinical importance Serum amyloid A measurements on D1 and D2 of hospitalization likely reflect both the severity of disease and response to initial treatment. Repeated SAA measurements during hospitalization can aid clinicians in determining severity of disease and can be useful as a prognosticator in ill neonatal foals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
- Department Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
Zitieren
APA
van den Brom-Spierenburg, A. J., Siegers, E. W., Westermann, C. M., Vernooij, J. C. M., Sloet van Oldruitenborgh-Oosterbaan, M. M., & Theelen, M. J. P. (2026). Sequential measurement of serum amyloid A concentrations in ill hospitalized neonatal foals. Journal of Veterinary Internal Medicine. https://doi.org/10.1093/jvimsj/aalag035
Vancouver
van den Brom-Spierenburg AJ, Siegers EW, Westermann CM, Vernooij JCM, Sloet van Oldruitenborgh-Oosterbaan MM, Theelen MJP. Sequential measurement of serum amyloid A concentrations in ill hospitalized neonatal foals. Journal of Veterinary Internal Medicine. 2026. doi:10.1093/jvimsj/aalag035
BibTeX
@article{vandenBromSpierenburg2026,
author = {van den Brom-Spierenburg, Astrid J and Siegers, Esther W and Westermann, Cornélie M and Vernooij, Johannes C M and Sloet van Oldruitenborgh-Oosterbaan, Marianne M and Theelen, Mathijs J P},
title = {Sequential measurement of serum amyloid A concentrations in ill hospitalized neonatal foals},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
doi = {10.1093/jvimsj/aalag035}
}
EUVIMED